Exact Sciences
EXAS
#1707
Rank
S$13.38 B
Marketcap
$72.33
Share price
1.12%
Change (1 day)
-17.00%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Cash on Hand

Cash on Hand as of September 2024 : S$1.37 Billion

According to Exact Sciences's latest financial reports the company has S$1.37 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Exact Sciences - Cash on Hand chart (from 2001 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$1.02 B21.21%
2022-12-31S$0.84 B-39.18%
2021-12-31S$1.39 B-42.77%
2020-12-31S$2.43 B457.86%
2019-12-31S$0.43 B-71.59%
2018-12-31S$1.53 B170.36%
2017-12-31S$0.56 B26.16%
2016-12-31S$0.45 B3.72%
2015-12-31S$0.43 B16.19%
2014-12-31S$0.37 B121.29%
2013-12-31S$0.16 B27.69%
2012-12-31S$0.13 B9.36%
2011-12-31S$0.12 B-1.63%
2010-12-31S$0.12 B259.86%
2009-12-31S$34.15 M383.74%
2008-12-31S$7.06 M-61.02%
2007-12-31S$18.11 M-43.95%
2006-12-31S$32.31 M-43.11%
2005-12-31S$56.8 M-30.74%
2004-12-31S$82.02 M73.62%
2003-12-31S$47.24 M-37.9%
2002-12-31S$76.07 M-27.7%
2001-12-31S$0.10 B129.37%
2000-12-31S$45.87 M675.44%
1999-12-31S$5.91 M-59.4%
1998-12-31S$14.57 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$0.13 B-90.47%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.36 B-73.16%๐Ÿ‡บ๐Ÿ‡ธ USA
S$8.94 M-99.35%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.81 B 613.34%๐Ÿ‡ซ๐Ÿ‡ท France